-
Product Insights
NewAurora Kinase B – Drugs In Development, 2024
The Aurora Kinase B pipeline drugs market research report outlays comprehensive information on the Aurora Kinase B targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology which include indications of Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia), and Gastric Cancer. It also reviews key players involved in Aurora Kinase B targeted therapeutics development with respective active and...
-
Product Insights
NewCD27 Antigen – Drugs In Development, 2024
The CD27 Antigen pipeline drugs market research report outlays comprehensive information on the CD27 Antigen targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, and Immunology which include indications of Solid Tumor, Unspecified B-Cell Lymphomas, Autoimmune Disorders, and Inflammation. It also reviews key players involved in CD27 Antigen targeted therapeutics development with respective active and dormant or...
-
Product Insights
NewN Sulphoglucosamine Sulphohydrolase – Drugs In Development, 2024
The N Sulphoglucosamine Sulphohydrolase pipeline drugs market research report outlays comprehensive information on the N Sulphoglucosamine Sulphohydrolase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Metabolic Disorders which include indications of Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ). It also reviews key players involved in N Sulphoglucosamine Sulphohydrolase targeted therapeutics development with respective active and dormant or...
-
Product Insights
NewGTPase NRas – Drugs In Development, 2024
The GTPase NRas pipeline drugs market research report outlays comprehensive information on the GTPase NRas targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology which include indications of Solid Tumor, and Non-Small Cell Lung Cancer. It also reviews key players involved in GTPase NRas targeted therapeutics development with respective active and dormant or discontinued projects. Note: *...
-
Product Insights
NewWerner Syndrome ATP Dependent Helicase – Drugs In Development, 2024
The Werner Syndrome ATP Dependent Helicase pipeline drugs market research report outlays comprehensive information on the Werner Syndrome ATP Dependent Helicase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology which include indications of Unspecified Cancer, and Solid Tumor. It also reviews key players involved in Werner Syndrome ATP Dependent Helicase targeted therapeutics development with respective active...
-
Product Insights
NewCyclin Dependent Kinase 1 – Drugs In Development, 2024
The Cyclin Dependent Kinase 1 pipeline drugs market research report outlays comprehensive information on the Cyclin Dependent Kinase 1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology which include indications of Solid Tumor, and Mantle Cell Lymphoma. It also reviews key players involved in Cyclin Dependent Kinase 1 targeted therapeutics development with respective active and dormant...
-
Product Insights
NewMonoglyceride Lipase – Drugs In Development, 2024
The Monoglyceride Lipase pipeline drugs market research report outlays comprehensive information on the Monoglyceride Lipase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System which include indications of Substance (Drug) Abuse, and Unspecified Neurologic Disorders. It also reviews key players involved in Monoglyceride Lipase targeted therapeutics development with respective active and dormant or discontinued projects....
-
Product Insights
NewTranscriptional Coactivator YAP1 – Drugs In Development, 2024
The Transcriptional Coactivator YAP1 pipeline drugs market research report outlays comprehensive information on the Transcriptional Coactivator YAP1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology which include indications of Solid Tumor, and Unspecified Cancer. It also reviews key players involved in Transcriptional Coactivator YAP1 targeted therapeutics development with respective active and dormant or discontinued projects. Note:...
-
Product Insights
NewDouble Homeobox Protein 4 – Drugs In Development, 2024
The Double Homeobox Protein 4 pipeline drugs market research report outlays comprehensive information on the Double Homeobox Protein 4 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Musculoskeletal Disorders which include indications of Facioscapulohumeral Muscular Dystrophy (FSHD). It also reviews key players involved in Double Homeobox Protein 4 targeted therapeutics development with respective active and dormant or...
-
Product Insights
NewCyclin Dependent Kinase 12 – Drugs In Development, 2024
The Cyclin Dependent Kinase 12 pipeline drugs market research report outlays comprehensive information on the Cyclin Dependent Kinase 12 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology which include indications of Breast Cancer, and Ovarian Cancer. It also reviews key players involved in Cyclin Dependent Kinase 12 targeted therapeutics development with respective active and dormant or...